Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioInno Bioscience provides comprehensive CDMO services including cell line development, process development, clinical material production, regulatory support for IND/clinical filings, and cGMP manufacturing of biologics (proteins/antibodies), gene therapies (plasmids/viral vectors), and cell therapies. The company also develops custom serum-free cell culture media. It supports both early-stage and commercial-scale projects with flexible capacity up to 6000 L for recombinant proteins and 200 L microbial fermentation. No proprietary clinical results are reported since it does not develop its own therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioInno Bioscience.